Eli Lilly to invest .8 billion to expand manufacturing for weight loss, diabetes and Alzheimer’s drugs

Eli Lilly to invest $1.8 billion to expand manufacturing for weight loss, diabetes and Alzheimer’s drugs

Eli Lilly announced a $1.8 billion investment to increase manufacturing capacity for its Alzheimer’s drug and popular weight loss and diabetes treatments in Ireland. The company is expanding existing sites in Limerick and Kinsale to meet growing demand for their medications, including the recently approved Alzheimer’s treatment Kisunla. The investment aims to ensure a stable…

Read More